{"ticker": {"uuid": "3db2332e-60f3-4dbb-ae46-839dba31e78a", "symbol": "206A", "name": "PRISM BioLab Co.,LTD", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Special Stock Report PRISM Bio (5.50%) SBI Securities", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNZGVQMEpJTEU3Qk1NeXJZa0JEdy1zYW1CMGJ4WHVTRzhmRjZrMkxEWlE1bG9DYzZMbTB2bld2ZTBXWjFaUkJKSDYyQWMyN0hsajhIZWFBeFIybnFqV0ZHdWV5OEVyZVU3VzY5SE9WUjJpZUFVU2h4Z3pvY0hMMGhIUTB2ZjBvcUQzQzFjVFJMNXB6WHE5YWdn?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T07:37:00+00:00", "published_display": "07 Jul 2026 07:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think PRISM BioLabLTD (TSE:206A) Can Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxQTjJDZGI1MjYzeG94TmVlOUV0UHc4M0hDOU54MjRvREpWd1RwYkxnMVhhcGx5bXNicW8zSE1GaG5hZUN2R2NlUDdiWlk0WHQ4M3k3TUdCME1KeVp5ZDZLd3dhNHhydjMyQWZGMWJ5d3Nid3Bpc1MtM3Q3YXo3bXdrNlN6bC15ZHdGUGVyMnVPU1h1UlRic1E1Q1Z1T1Vxc2NVS1hDaFBxNkdxRHRtNlg2bmNpNlpVUllkM0ZqS3dCbXpiNXNRa2c4NHRkbDBESHp2Nl9xeDBuMC1abnZpZzg3dHUwcVItUlhz0gHuAUFVX3lxTE9aV3lQcGRPalJZSXB5d3FhTnlMeHZxeDNwRzZ2WDFheDg0ZzZ2U2NhZ1pMbzJfWmxJZkRIVWJGT3Y4QXNyQjVGb29YbF9rRHdzRVRZUG51a0NwT185enJJSkg4Q013ZnlrZ25LdElSTkxtNGQtZFhOOEhVWm96RFZDaEdzWWxPbEpkdkNoX1RYRGtNRHNzaWhCWkhnSjd6RUJjRG05Vk00UG1sMFN6NmhBWTVuOGxzQUlweXdfVG1SX1BJeGozVGpEbHdveXJSRTd6TVdiOFhBVWMwUjJhR2RyTVB4R2I0NE9KTGJlVHc?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNTlU2akh2aUlVaXBjaHZ0bTd2N3VrVklCVDEwUm5BNW5WU1Nuenc4b2NnS29jSW9Wd29ETUZ1S3NFdlpoSTVVdlZiaEk1RHRvMDNXVTRVdXMzUUdUb3N6amZGOVZoaFl1a1MwSVhnTV9zaUZ4NWNPdzRseXZsNU5Qbnk1bHIxQTlYYVF1UEo1MTNvU0szN0YtRURJbEZmdXczdnhqX2xqWHhEaC1DTkw5cmxCQ0lyZURzNV82RS1mSExRYmROSmR5M2oxQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMingJBVV95cUxPcTN4YnA4anZYN29JakdMVkk0LVdGakY5Z0twVUtXQUEtVG9tZkNvVFhBN3dCVDdjMDBXTlEybkpNY3RaSHRPckxMQURGWEFvcWhFNldUTTd5SExLMFpTWGpfcXNaSG9vN0hqaHp6QTV2bUNqMWY2bHRzTk9XWDl0a09VcXh5cTh6Sk5JNkFSbFY0dXBqRDdHeUpQMkJRQjR3SVN0c3RfV2dhbnR0ZlJvVVNidExsNDhRd1JRazRYTXp3MTBrOFBFWjJZTlFlR3FNTDlsU0VaSXJ5ZkR4OXJuTFlMSWo3cUhKQklMZ05jblNqZTZhbEVoTVVsUk5WR3lZRk9kNGNKc29UZ1lEOGpONXJBck40WEhlV0FkWTJ3?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVHN3Yy1fel9UQnZiZlZGYTc2V0piLXhGSVJCc0RaWHNDQ2xES3ZoeFYwSGR0OVJ2MkVsQnhydVNvRkdRcmphZDY3MEg4Mk1jVGNkN0EtQUtVM25wcjREajVLTDdKUUxHSVJMS3hNdWxjNzhkMC1EVkw5YXJpS213VXdoakVnX3RzVVprUjBaLUVBUkNGeUhFbzdobUtyWE1ERXFob1hXLVhjbi12bHhkR1pXZ2FGRUNzYnZXN2xiNzdIclh3X2lXOUZJRGxnMUt6S0JLcWdnYzNwek0?oc=5", "source_name": "PR Newswire", "published_at": "2022-01-04T08:00:00+00:00", "published_display": "04 Jan 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Special Stock Report PRISM Bio (5.50%) SBI Securities", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNZGVQMEpJTEU3Qk1NeXJZa0JEdy1zYW1CMGJ4WHVTRzhmRjZrMkxEWlE1bG9DYzZMbTB2bld2ZTBXWjFaUkJKSDYyQWMyN0hsajhIZWFBeFIybnFqV0ZHdWV5OEVyZVU3VzY5SE9WUjJpZUFVU2h4Z3pvY0hMMGhIUTB2ZjBvcUQzQzFjVFJMNXB6WHE5YWdn?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T07:37:00+00:00", "published_display": "07 Jul 2026 07:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think PRISM BioLabLTD (TSE:206A) Can Afford To Drive Business Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNTlU2akh2aUlVaXBjaHZ0bTd2N3VrVklCVDEwUm5BNW5WU1Nuenc4b2NnS29jSW9Wd29ETUZ1S3NFdlpoSTVVdlZiaEk1RHRvMDNXVTRVdXMzUUdUb3N6amZGOVZoaFl1a1MwSVhnTV9zaUZ4NWNPdzRseXZsNU5Qbnk1bHIxQTlYYVF1UEo1MTNvU0szN0YtRURJbEZmdXczdnhqX2xqWHhEaC1DTkw5cmxCQ0lyZURzNV82RS1mSExRYmROSmR5M2oxQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.", "summary": "", "url": "https://news.google.com/rss/articles/CBMingJBVV95cUxPcTN4YnA4anZYN29JakdMVkk0LVdGakY5Z0twVUtXQUEtVG9tZkNvVFhBN3dCVDdjMDBXTlEybkpNY3RaSHRPckxMQURGWEFvcWhFNldUTTd5SExLMFpTWGpfcXNaSG9vN0hqaHp6QTV2bUNqMWY2bHRzTk9XWDl0a09VcXh5cTh6Sk5JNkFSbFY0dXBqRDdHeUpQMkJRQjR3SVN0c3RfV2dhbnR0ZlJvVVNidExsNDhRd1JRazRYTXp3MTBrOFBFWjJZTlFlR3FNTDlsU0VaSXJ5ZkR4OXJuTFlMSWo3cUhKQklMZ05jblNqZTZhbEVoTVVsUk5WR3lZRk9kNGNKc29UZ1lEOGpONXJBck40WEhlV0FkWTJ3?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVHN3Yy1fel9UQnZiZlZGYTc2V0piLXhGSVJCc0RaWHNDQ2xES3ZoeFYwSGR0OVJ2MkVsQnhydVNvRkdRcmphZDY3MEg4Mk1jVGNkN0EtQUtVM25wcjREajVLTDdKUUxHSVJMS3hNdWxjNzhkMC1EVkw5YXJpS213VXdoakVnX3RzVVprUjBaLUVBUkNGeUhFbzdobUtyWE1ERXFob1hXLVhjbi12bHhkR1pXZ2FGRUNzYnZXN2xiNzdIclh3X2lXOUZJRGxnMUt6S0JLcWdnYzNwek0?oc=5", "source_name": "PR Newswire", "published_at": "2022-01-04T08:00:00+00:00", "published_display": "04 Jan 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 4, "score": 53, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 161.0, "latest_week": "2026-07-10", "one_week_move": 13.4, "four_week_move": 22.0, "twelve_week_move": -17.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.029474, "market_dynamics_buy_signal": false, "relative_strength": -30.151809, "fair_value_gap": -37.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.7225, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+13.4% over one week, +22.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 3}, {"label": "Moomoo", "count": 1}, {"label": "simplywall.st", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+13.4% over one week, +22.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Special Stock Report PRISM Bio (5.50%) SBI Securities"}], "updated_at": "2026-07-17T06:17:22.408978+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}